CytoDyn Provides Update on PRO 140 Pivotal Combination Therapy Trial in Patients with HIV
Aug 21, 2017 10:00 am UTC| Business
VANCOUVER, Washington, Aug. 21, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that...
Aug 21, 2017 10:00 am UTC| Business
SAN DIEGO, Aug. 21, 2017 -- MatriSys Bioscience, a leader in the field of microbiome-based therapeutics for the treatment of skin conditions, today announced that the first patient has been dosed in a Phase 2A clinical...
Aug 21, 2017 10:00 am UTC| Business
CHICAGO, Aug. 21, 2017 -- TransUnion (NYSE:TRU) today announced that it has appointed the honorable Katharina McFarland to its Government Advisory Board. The Advisory Board provides TransUnion with valuable perspective...
Aug 21, 2017 10:00 am UTC| Business
EDISON, N.J., Aug. 21, 2017 -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the United...
Aug 21, 2017 09:33 am UTC| Business
LONDON, Aug. 21, 2017 -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases,...
Aug 21, 2017 09:32 am UTC| Business
In response to market rumors regarding a potential interest of Great Wall Motors in the Jeep brand, Fiat Chrysler Automobiles ("FCA") (NYSE: FCAU MTA: FCA) confirmed that it has not been approached by Great Wall Motors in...
Aug 21, 2017 09:00 am UTC| Business
TAINAN, Taiwan, Aug. 21, 2017 -- Himax Technologies, Inc. (Nasdaq:HIMX) (“Himax” or “Company”), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that the...